Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

Sabril

Known as: Sabrilex 
 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2014
2014
Macrophages activated by the gram negative bacterial product lipopolysaccharide (LPS) switch their core metabolism from oxidative… Expand
  • figure 1
  • figure 2
  • figure 3
  • figure 4
Is this relevant?
2008
2008
Vigabatrin (Sabril) is an antiepileptic drug indicated for the treatment of partial epilepsy, which is only licensed as first… Expand
Is this relevant?
2006
2006
A 52 year old woman presented with neuropathic pain in both legs. Clinical neurological and neurophysiological examinations… Expand
Is this relevant?
2004
2004
PURPOSE A case control study was conducted to assess the effect of Sabril (Vigabatrin), Lamictal (Lamotrigine) and Neurontin… Expand
  • table 3
  • table 5
  • table 4
  • table 4
Is this relevant?
2000
2000
Purpose: Vigabatrin (Sabril), a drug that blocks GABA transaminase, has been used in the treatment of epilepsy since 1989. There… Expand
  • table 1
  • figure 1
  • figure 2
Is this relevant?
1995
1995
Vigabatrin (VGB) prevents seizures by irreversible inhibition of gamma-aminobutyric acid (GABA) transaminase and a resulting… Expand
Is this relevant?
Review
1994
Review
1994
Vigabatrin (VGB, Sabril) is a new antiepileptic drug used for treatment of partial and secondarily generalized tonic-clonic… Expand
Is this relevant?
1993
1993
The novel antiepileptic drug vigabatrin (Sabril) acts by inhibiting degradation of the inhibitory neurotransmitter gamma… Expand
Is this relevant?
1993
1993
Vigabatrin (Sabril®) is a γ-aminobutyric acid-transaminase (GABA-T) inhibitor that is effective in the treatment of certain types… Expand
  • table I
  • figure 1
  • figure 2
  • figure 3
  • figure 5
Is this relevant?
1991
1991
Ten patients, suffering from drug-resistant complex partial seizures were treated for a period of up to 3 years with vigabatrin… Expand
  • table 1
  • figure 1
  • table 2
  • figure 2
  • table 3
Is this relevant?